ARTICLE | Company News
Savient, Teva in acquisition talks
October 3, 2003 7:00 AM UTC
Specialty pharma company SVNT said it is in talks to be acquired by TEVA for a cash sum that "approximates" SVNT's Thursday close price of $6.14. This would value SVNT (formerly Bio-Technology General...